 Lauren Vanderlinden
Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcohol Drinking | 6 | 2018 | 651 | 1.120 |
Why?
| | Quantitative Trait Loci | 5 | 2020 | 305 | 0.680 |
Why?
| | Rats, Inbred Strains | 4 | 2019 | 362 | 0.680 |
Why?
| | Quantitative Trait, Heritable | 2 | 2017 | 116 | 0.570 |
Why?
| | Gene Regulatory Networks | 4 | 2019 | 228 | 0.560 |
Why?
| | Darkness | 1 | 2015 | 23 | 0.480 |
Why?
| | DNA Methylation | 4 | 2020 | 495 | 0.480 |
Why?
| | Brain | 7 | 2017 | 2371 | 0.450 |
Why?
| | Alcoholism | 3 | 2014 | 713 | 0.440 |
Why?
| | Circadian Rhythm | 1 | 2015 | 354 | 0.390 |
Why?
| | Genetic Predisposition to Disease | 5 | 2020 | 2085 | 0.380 |
Why?
| | Phenotype | 2 | 2015 | 2796 | 0.350 |
Why?
| | Systems Biology | 2 | 2019 | 54 | 0.300 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2020 | 3252 | 0.230 |
Why?
| | Ethanol | 2 | 2018 | 538 | 0.220 |
Why?
| | Rats | 9 | 2019 | 4958 | 0.220 |
Why?
| | Mice, Inbred Strains | 2 | 2015 | 396 | 0.220 |
Why?
| | Adiposity | 2 | 2017 | 457 | 0.210 |
Why?
| | Metabolomics | 4 | 2020 | 521 | 0.210 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1518 | 0.200 |
Why?
| | Lipid Metabolism | 3 | 2019 | 444 | 0.190 |
Why?
| | Oxylipins | 1 | 2020 | 27 | 0.180 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2020 | 16 | 0.170 |
Why?
| | Animals | 14 | 2020 | 31698 | 0.170 |
Why?
| | Genotype | 2 | 2015 | 1760 | 0.170 |
Why?
| | Anthracenes | 1 | 2019 | 27 | 0.160 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 97 | 0.160 |
Why?
| | Eicosanoids | 1 | 2019 | 54 | 0.160 |
Why?
| | Fluorenes | 1 | 2019 | 38 | 0.160 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 9 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.150 |
Why?
| | Metabolic Clearance Rate | 1 | 2018 | 102 | 0.150 |
Why?
| | Transcriptome | 3 | 2018 | 725 | 0.150 |
Why?
| | Phthalic Acids | 1 | 2018 | 28 | 0.150 |
Why?
| | Male | 17 | 2020 | 55579 | 0.150 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 34 | 0.150 |
Why?
| | Fatty Acids | 2 | 2017 | 381 | 0.150 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2017 | 5 | 0.150 |
Why?
| | GABA Modulators | 1 | 2017 | 7 | 0.150 |
Why?
| | CD24 Antigen | 1 | 2017 | 20 | 0.140 |
Why?
| | Genetic Association Studies | 2 | 2020 | 339 | 0.140 |
Why?
| | Multifactorial Inheritance | 1 | 2018 | 122 | 0.140 |
Why?
| | Seizures | 1 | 2020 | 340 | 0.140 |
Why?
| | Islets of Langerhans | 2 | 2020 | 726 | 0.140 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 307 | 0.140 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 82 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2018 | 138 | 0.140 |
Why?
| | Voltage-Gated Sodium Channels | 1 | 2016 | 4 | 0.130 |
Why?
| | Diet | 2 | 2020 | 1080 | 0.130 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 172 | 0.130 |
Why?
| | Food Hypersensitivity | 1 | 2020 | 251 | 0.130 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 82 | 0.130 |
Why?
| | Hippocampus | 1 | 2020 | 693 | 0.130 |
Why?
| | Obesity | 2 | 2017 | 2508 | 0.120 |
Why?
| | Quinolines | 1 | 2016 | 129 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 439 | 0.120 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2015 | 15 | 0.120 |
Why?
| | Birth Weight | 1 | 2017 | 440 | 0.120 |
Why?
| | Microarray Analysis | 1 | 2015 | 118 | 0.120 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2017 | 196 | 0.120 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 180 | 0.120 |
Why?
| | Neuralgia | 1 | 2016 | 122 | 0.120 |
Why?
| | Cell Nucleus | 1 | 2017 | 554 | 0.120 |
Why?
| | Principal Component Analysis | 1 | 2015 | 175 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2020 | 1879 | 0.110 |
Why?
| | Genetic Variation | 1 | 2019 | 870 | 0.110 |
Why?
| | Female | 14 | 2020 | 59488 | 0.110 |
Why?
| | Behavior, Addictive | 1 | 2014 | 81 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 347 | 0.110 |
Why?
| | Mice | 5 | 2017 | 14863 | 0.110 |
Why?
| | Neurons | 2 | 2020 | 1279 | 0.110 |
Why?
| | Insulin | 2 | 2020 | 2078 | 0.110 |
Why?
| | Species Specificity | 1 | 2014 | 542 | 0.110 |
Why?
| | Choice Behavior | 1 | 2014 | 155 | 0.100 |
Why?
| | Adenylyl Cyclases | 1 | 2012 | 83 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 800 | 0.100 |
Why?
| | Gene Expression | 1 | 2017 | 1421 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 979 | 0.100 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2012 | 72 | 0.100 |
Why?
| | Placenta | 1 | 2018 | 625 | 0.100 |
Why?
| | Ibuprofen | 1 | 2012 | 75 | 0.100 |
Why?
| | Autoantibodies | 1 | 2019 | 1346 | 0.100 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 117 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 4 | 2020 | 2218 | 0.100 |
Why?
| | Lipocalin 1 | 1 | 2011 | 2 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1040 | 0.090 |
Why?
| | Blastocyst | 1 | 2011 | 44 | 0.090 |
Why?
| | Base Sequence | 1 | 2015 | 2114 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2017 | 488 | 0.090 |
Why?
| | Culture Media | 1 | 2011 | 155 | 0.090 |
Why?
| | Models, Genetic | 1 | 2013 | 562 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2012 | 154 | 0.090 |
Why?
| | Liver | 1 | 2018 | 1637 | 0.090 |
Why?
| | Aneuploidy | 1 | 2011 | 85 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2017 | 2186 | 0.090 |
Why?
| | Autoimmunity | 3 | 2020 | 813 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2785 | 0.090 |
Why?
| | Postpartum Period | 1 | 2012 | 278 | 0.090 |
Why?
| | Sex Factors | 1 | 2015 | 1715 | 0.080 |
Why?
| | Depressive Disorder, Major | 1 | 2012 | 301 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 167 | 0.080 |
Why?
| | Infant | 5 | 2020 | 7959 | 0.080 |
Why?
| | Extracellular Matrix | 1 | 2012 | 436 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2020 | 3003 | 0.080 |
Why?
| | Genome-Wide Association Study | 1 | 2014 | 1177 | 0.080 |
Why?
| | Asthma | 1 | 2020 | 2029 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2014 | 2552 | 0.070 |
Why?
| | Humans | 17 | 2020 | 114654 | 0.070 |
Why?
| | Rats, Inbred BN | 2 | 2018 | 52 | 0.070 |
Why?
| | Pregnancy | 4 | 2020 | 5517 | 0.070 |
Why?
| | Child, Preschool | 4 | 2020 | 9111 | 0.070 |
Why?
| | Signal Transduction | 1 | 2019 | 4512 | 0.070 |
Why?
| | Proteomics | 1 | 2011 | 836 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 520 | 0.060 |
Why?
| | Child | 5 | 2020 | 18407 | 0.060 |
Why?
| | Up-Regulation | 2 | 2019 | 807 | 0.050 |
Why?
| | Seroconversion | 1 | 2020 | 45 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 45 | 0.040 |
Why?
| | Kainic Acid | 1 | 2020 | 31 | 0.040 |
Why?
| | HLA-DR4 Antigen | 1 | 2020 | 76 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2020 | 79 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 2 | 2012 | 411 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 122 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 45 | 0.040 |
Why?
| | Chimera | 1 | 2019 | 59 | 0.040 |
Why?
| | Receptors, AMPA | 1 | 2020 | 119 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 331 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 477 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2018 | 15 | 0.040 |
Why?
| | Rats, Inbred SHR | 1 | 2018 | 41 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2019 | 217 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 164 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 94 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 260 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 236 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 415 | 0.040 |
Why?
| | Radioligand Assay | 1 | 2017 | 43 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 125 | 0.040 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.040 |
Why?
| | Carnitine | 1 | 2017 | 62 | 0.040 |
Why?
| | Electron Transport | 1 | 2017 | 108 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1075 | 0.040 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2017 | 43 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2019 | 785 | 0.040 |
Why?
| | Umbilical Cord | 1 | 2017 | 80 | 0.040 |
Why?
| | Models, Animal | 1 | 2019 | 344 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 77 | 0.030 |
Why?
| | Xenopus laevis | 1 | 2017 | 118 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2017 | 5044 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 384 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 98 | 0.030 |
Why?
| | Risk Factors | 2 | 2020 | 8631 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 144 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 275 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 201 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1143 | 0.030 |
Why?
| | Sodium Channel Blockers | 1 | 2016 | 23 | 0.030 |
Why?
| | Cricetulus | 1 | 2016 | 97 | 0.030 |
Why?
| | CHO Cells | 1 | 2016 | 138 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 141 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 442 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 253 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 630 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 849 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 31 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 698 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 338 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1569 | 0.030 |
Why?
| | Software | 1 | 2019 | 530 | 0.030 |
Why?
| | Biomarkers | 2 | 2017 | 3408 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 805 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 2015 | 176 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2015 | 368 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 923 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1168 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 448 | 0.030 |
Why?
| | Lipids | 1 | 2017 | 580 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 591 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1167 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2635 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2380 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1644 | 0.030 |
Why?
| | Basement Membrane | 1 | 2012 | 30 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 447 | 0.030 |
Why?
| | Young Adult | 2 | 2018 | 10465 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2017 | 731 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 34 | 0.030 |
Why?
| | Models, Molecular | 1 | 2017 | 1369 | 0.030 |
Why?
| | Laminin | 1 | 2012 | 69 | 0.030 |
Why?
| | Mitochondria | 1 | 2017 | 747 | 0.030 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 162 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 452 | 0.020 |
Why?
| | Mothers | 1 | 2017 | 651 | 0.020 |
Why?
| | RNA | 1 | 2017 | 809 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1076 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1018 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2012 | 127 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 448 | 0.020 |
Why?
| | Embryo Culture Techniques | 1 | 2011 | 12 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2387 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4411 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2017 | 1700 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 318 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 1958 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1578 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4407 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3327 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 347 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4622 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6115 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 6217 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2319 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 797 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2362 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4099 | 0.020 |
Why?
| | Adult | 2 | 2018 | 30542 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1796 | 0.020 |
Why?
| | Inflammation | 1 | 2016 | 2478 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 3885 | 0.020 |
Why?
| | Adolescent | 1 | 2020 | 17837 | 0.010 |
Why?
|
|
Vanderlinden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|